Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity

Microbiology and Immunology

Volumn 45, Issue 7, 2001, Pages 521-530

  Foda, Mohamed ^a   Harada, Shinji ^a   Maeda, Yosuke ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

CCR5; Coreceptor; Dualtropic; HIV 1

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ARTICLE; CELL GROWTH; CELL INTERACTION; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MORPHOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034913033     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2001.tb02653.x     Document Type: Article

References (40)

1. CC CKR5: A RANTES, MIP-1α MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV- 1
2. A new classification for HIV-1
3. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor
4. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein
5. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells
6. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
7. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses
8. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor
9. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation
10. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4
11. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
12. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
13. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
14. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research
15. Identification of a major co-receptor for primary isolates of HIV-1
16. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
17. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
18. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
19. HIV type 1 envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
20. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization
21. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection
22. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism
23. Factors affecting cellular tropism of human immunodeficiency virus
24. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
25. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
26. DH12 isolate
27. Chemokine receptors: Keys to AIDS pathogenesis?
28. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1α
29. Co-receptors for HIV-1 entry
30. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism
31. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
32. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop
33. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
34. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding
35. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate
36. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
37. Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication
38. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread
39. The antigenic structure of the HIV gp120 envelope glycoprotein
40. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions